Periodic Reporting for period 1 - HifLICs (Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse)

Acute Myeloid Leukemia (AML) is a heterogeneous disease that originates from diverse genetic alterations. It can be classified into different cytogenetic groups with variable prognosis. Unfortunately, treatment of AML has not improved over the last 30 years and cure rates...